Ladan Fazli
Researcher Next ID · RN-033073
Researcher · Biochemistry, Genetics and Molecular Biology
University of British Columbia
Vancouver, Canada
- Works count
- 799
- Citation count
- 20,252
- H-index
- 80
- i10-index
- 239
Research interests
Publications
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer
Nature Communications · 2021 · https://doi.org/10.1038/s41467-020-20493-6
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer
Nature Cell Biology · 2021 · https://doi.org/10.1038/s41556-021-00743-5
IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling
Nature Communications · 2019 · 10.1038/s41467-018-08152-3
ONECUT2 is a driver of neuroendocrine prostate cancer
Nature Communications · 2019 · https://doi.org/10.1038/s41467-018-08133-6
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer
European Urology · 2019 · https://doi.org/10.1016/j.eururo.2018.12.042
Automatic grading of prostate cancer in digitized histopathology images: Learning from multiple experts
Medical Image Analysis · 2018 · 10.1016/j.media.2018.09.005
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-15-1263
Targeting ASCT2 ‐mediated glutamine uptake blocks prostate cancer growth and tumour development
The Journal of Pathology · 2015 · 10.1002/path.4518
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein
Cancer Cell · 2015 · 10.1016/j.ccell.2015.09.003
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
Cell Reports · 2015 · https://doi.org/10.1016/j.celrep.2015.07.012
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
Cancer Research · 2013 · https://doi.org/10.1158/0008-5472.can-13-2921-t
Hsp27 Regulates Epithelial Mesenchymal Transition, Metastasis, and Circulating Tumor Cells in Prostate Cancer
Cancer Research · 2013 · 10.1158/0008-5472.can-12-3979
Targeting Amino Acid Transport in Metastatic Castration-Resistant Prostate Cancer: Effects on Cell Cycle, Cell Growth, and Tumor Development
JNCI Journal of the National Cancer Institute · 2013 · 10.1093/jnci/djt241
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
The Journal of Pathology · 2012 · https://doi.org/10.1002/path.4047
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
The EMBO Journal · 2011 · 10.1038/emboj.2011.158
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
Nature Medicine · 2010 · https://doi.org/10.1038/nm.2236
Insulin receptor expression by human prostate cancers
The Prostate · 2008 · 10.1002/pros.20852
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
BMC Cancer · 2008 · 10.1186/1471-2407-8-230
Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers
Journal of Clinical Pathology · 2007 · 10.1136/jcp.2006.043810
Intraprostatic Androgens and Androgen-Regulated Gene Expression Persist after Testosterone Suppression: Therapeutic Implications for Castration-Resistant Prostate Cancer
Cancer Research · 2007 · 10.1158/0008-5472.can-06-3332
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development
Proceedings of the National Academy of Sciences · 2007 · https://doi.org/10.1073/pnas.0703942104
Cooperative Interactions between Androgen Receptor (AR) and Heat-Shock Protein 27 Facilitate AR Transcriptional Activity
Cancer Research · 2007 · 10.1158/0008-5472.can-07-2057
A Phase I Pharmacokinetic and Pharmacodynamic Study of OGX-011, a 2′-Methoxyethyl Antisense Oligonucleotide to Clusterin, in Patients With Localized Prostate Cancer
JNCI Journal of the National Cancer Institute · 2005 · 10.1093/jnci/dji252
Increased Hsp27 after Androgen Ablation Facilitates Androgen-Independent Progression in Prostate Cancer via Signal Transducers and Activators of Transcription 3–Mediated Suppression of Apoptosis
Cancer Research · 2005 · 10.1158/0008-5472.can-05-1840
Heat Shock Protein 27 Increases after Androgen Ablation and Plays a Cytoprotective Role in Hormone-Refractory Prostate Cancer
Cancer Research · 2004 · 10.1158/0008-5472.can-03-3998
Regulation of tumor angiogenesis by integrin-linked kinase (ILK)
Cancer Cell · 2004 · 10.1016/s1535-6108(03)00281-2
Current projects
No projects listed.